VPF
ABBV icon

Vantage Point Financial’s AbbVie ABBV Stock Holding History

Vantage Point Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Sell
1,442
-9
-0.6% -$1.94K 0.11% 121
2026
Q1 		$316K Sell
1,451
-25
-2% -$5.55K 0.11% 125
2025
Q4 		$337K Buy
1,476
+42
+3% +$9.57K 0.12% 114
2025
Q3 		$332K Buy
1,434
+17
+1% +$3.46K 0.13% 109
2025
Q2 		$263K Sell
1,417
-41
-3% -$7.62K 0.12% 121
2025
Q1 		$305K Buy
1,458
+302
+26% +$58.7K 0.15% 97
2024
Q4 		$205K Buy
+1,156
New +$213K 0.11% 119

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vantage Point Financial's ABBV Position: Q2 2026 in Review

Vantage Point Financial reduced its AbbVie (ABBV) stake by 0.62% in Q2 2026, selling an estimated $1.94K and leaving 1,442 shares worth $363K. The position accounts for 0.11% of the portfolio, ranked #121.

Vantage Point Financial first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vantage Point Financial held 1,442 shares of AbbVie worth $363K as of Q2 2026.
  • Vantage Point Financial sold 9 AbbVie shares in Q2 2026, an estimated $1.94K.
  • AbbVie made up 0.11% of Vantage Point Financial's portfolio in Q2 2026, its #121 holding.
  • Vantage Point Financial first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vantage Point Financial's 13F filing for Q2 2026, filed 14 Aug 2026.